BeOne Medicines Ltd
238 hedge funds and large institutions have $10.4B invested in BeOne Medicines Ltd in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 99 increasing their positions, 78 reducing their positions, and 42 closing their positions.
69% more call options, than puts
Call options by funds: $23.6M | Put options by funds: $14M
27% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 78
0.04% less ownership
Funds ownership: 4.17% → 4.13% (-0.04%)
9% less funds holding
Funds holding: 262 → 238 (-24)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
31% less capital invested
Capital invested by funds: $15B → $10.4B (-$4.65B)
48% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 42
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$144M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$93.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$59.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$45M |
| 5 |
ICP
Indus Capital Partners
New York
|
-$28.8M |
ONC Hedge Fund Activity: Q1 2022 in Review
238 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2022, worth a combined $10.4B — down 31% from $15B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of ONC and 22 opened new positions — a net loss of 20 holders — while 78 trimmed existing stakes and 99 added.
The largest buyer was Capital International Investors, adding an estimated $151M. The largest seller was Wellington Management Group, cutting an estimated $144M.
- 238 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2022, down from 262 in Q4 2021.
- Funds reported $10.4B of BeOne Medicines Ltd stock for Q1 2022, down 31% quarter-over-quarter.
- 22 funds opened new BeOne Medicines Ltd positions in Q1 2022 and 42 closed out, a net change of -20 holders.
- The largest BeOne Medicines Ltd buyer in Q1 2022 was Capital International Investors, an estimated $151M added.
- The largest BeOne Medicines Ltd seller in Q1 2022 was Wellington Management Group, an estimated $144M sold.
Based on aggregated 13F filings for Q1 2022.